Cure Forward, a clinical trial service for cancer patients, is suspending its services
MedCity News | May 26, 2017
Cure Forward, a Cambridge, Massachusetts digital health startup to connect and enroll cancer patients to relevant clinical trials, has suspended its services, according to its website. The company zeroed in on the disconnect between patients and awareness of clinical trials relevant to them as one way to solve the most costly and prolonged part of drug development — clinical trial recruitment.